Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia.
J Comp Eff Res
; 8(13): 1111-1123, 2019 10.
Article
em En
| MEDLINE
| ID: mdl-31432687
ABSTRACT
Aim:
Objective was to compare adherence and persistence, as well as direct healthcare costs and utilization, of ospemifene to available local estrogen therapies (LETs). Patients &methods:
This retrospective database study used integrated medical and pharmacy claims data from the IQVIA Real-World Data Adjudicated Claims - US Database.Results:
Ospemifene patients had significantly greater adherence and persistence compared with the other nonring LETs. Ospemifene had the lowest mean outpatient costs of any of the LET cohorts, including the estradiol vaginal ring. Total all-cause healthcare costs were also significantly less for ospemifene patients compared with all other LETs.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tamoxifeno
/
Dispareunia
/
Estrogênios
Tipo de estudo:
Health_economic_evaluation
/
Observational_studies
Limite:
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
J Comp Eff Res
Ano de publicação:
2019
Tipo de documento:
Article
País de afiliação:
Estados Unidos